SCHEMBL27375239

SCHEMBL27375239

NCc1cc(F)cc(-c2cnn(-c3ccccn3)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM5 P41594 2/20 0.49
▸ GRM4 Q14833 4/20 0.45
▸ ALKBH2 Q6NS38 1/20 0.41
▸ EGLN1 Q9GZT9 1/20 0.41
▸ DRD2 P14416 3/20 0.40
▸ DRD4 P21917 3/20 0.40
▸ DRD3 P35462 3/20 0.40
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ MET P08581 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ FFAR4 Q5NUL3 1/20 0.34
▸ LOXL2 Q9Y4K0 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ AOC3 Q16853 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ CYP17A1 P05093 1/20 0.33
▸ CYP21A2 P08686 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456934 1.00 GRM5 (0.49) GRM5GRM4ALKBH2EGLN1DRD2
SCHEMBL5217009 0.87 GRM5 (0.58) GRM5GRM4ALKBH2EGLN1DRD2
SCHEMBL27375741 0.83 LOXL2 (0.33) GRM5LOXL2MAOAKCNH2AOC3
SCHEMBL27374582 0.82 GRM4 (0.45) GRM4DRD2DRD4DRD3KCNH2
SCHEMBL31456940 0.82 GRM4 (0.45) GRM4DRD2DRD4DRD3KCNH2
Hydrochloric Acid SCHEMBL30751417 0.82 LOXL2 (0.34) GRM5LOXL2MAOAKCNH2AOC3
SCHEMBL3929204 0.79 GRM5 (0.66) GRM5GRM4ALKBH2EGLN1DRD2
SCHEMBL30795106 0.79 GRM5 (0.66) GRM5GRM4ALKBH2EGLN1DRD2
SCHEMBL31457020 0.79 CYP17A1 (0.43) GRM4LOXL2MAOACYP17A1CYP21A2
SCHEMBL27374758 0.79 CYP17A1 (0.43) GRM4LOXL2MAOACYP17A1CYP21A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 — — WO disclosed
Send feedback